Page 19 - ARNM-1-2

Advances in Radiotherapy
& Nuclear Medicine Advancements and challenges in radioactive iodine-125

29. Rohatgi P, Jafrani RJ, Brandmeir NJ, et al., 2018, Robotic- 39. Steel GG, 1991, The ESTRO Breur lecture. Cellular sensitivity
guided bihippocampal and biparahippocampal depth to low dose-rate irradiation focuses the problem of tumour
placement for responsive neurostimulation in bitemporal radioresistance. Radiother Oncol, 20: 71–83.
lobe epilepsy. World Neurosurg, 111: 181–189.
https://doi.org/10.1016/0167-8140(91)90140-c
https://doi.org/10.1016/j.wneu.2017.10.164
40. Williams JR, Zhang Y, Zhou H, et al., 2008, Overview of
30. Dhaliwal SS, Chettibi T, Wilby S, et al., 2021, Review of radiosensitivity of human tumor cells to low-dose-rate
clinical and technological consideration for MRI-guided irradiation. Int J Radiat Oncol Biol Phys, 72: 909–917.
robotic prostate brachytherapy. IEEE Trans Med Robot https://doi.org/10.1016/j.ijrobp.2008.06.1928
Bionics, 3: 583–605.
41. Baumann M, Dörr W, Petersen C, et al., 2003, Repopulation
https://doi.org/10.1109/TMRB.2021.3097127 during fractionated radiotherapy: Much has been learned,
31. Seifabadi R, Song SE, Krieger A, et al., 2012, Robotic system even more is open. Int J Radiat Biol, 79: 465–467.
for MRI-guided prostate biopsy: Feasibility of teleoperated https://doi.org/10.1080/0955300031000160259
needle insertion and ex vivo phantom study. Int J Comput
Assist Radiol Surg, 7: 181–190. 42. Zhang WF, Jin WD, Li B, et al., 2014, Effect of brachytherapy
on NF-kappaB and VEGF in gastric carcinoma xenografts.
https://doi.org/10.1007/s11548-011-0598-9 Oncol Rep, 32; 635–640.
32. Salcudean SE, Prananta TD, Morris WJ, et al., 2008, A https://doi.org/10.3892/or.2014.3255
Robotic Needle Guide for Prostate Brachytherapy. In:
2008 IEEE International Conference on Robotics and 43. Wang H, Li J, Qu A, et al., 2013, The different biological
Automation. effects of single, fractionated and continuous low dose rate
irradiation on CL187 colorectal cancer cells. Radiat Oncol,
33. Bodei L, Kassis AI, Adelstein SJ, et al., 2003, Radionuclide 8: 196.
therapy with iodine-125 and other auger-electron-
emitting radionuclides: Experimental models and clinical https://doi.org/10.1186/1748-717X-8-196
applications. Cancer Biother Radiopharm, 18: 861–877. 44. Hennequin C, Mazeron JJ, 2013, Radiobiology in
https://doi.org/10.1089/108497803322702833 brachytherapy. Cancer Radiother, 17: 81–84.
34. Welt S, Scott AM, Divgi CR, et al., 1996, Phase I/II study https://doi.org/10.1016/j.canrad.2013.03.001
of iodine 125-labeled monoclonal antibody A33 in patients 45. Halle C, Andersen E, Lando M, et al., 2012, Hypoxia-
with advanced colon cancer. J Clin Oncol, 14: 1787–1797. induced gene expression in chemoradioresistant cervical
https://doi.org/10.1200/JCO.1996.14.6.1787 cancer revealed by dynamic contrast-enhanced MRI. Cancer
Res, 72: 5285–5295.
35. Chargari C, Van Limbergen E, Mahantshetty U, et al., 2018,
Radiobiology of brachytherapy: The historical view based on https://doi.org/10.1158/0008-5472.CAN-12-1085
linear quadratic model and perspectives for optimization. 46. Barendsen GW, 1982, Dose fractionation, dose rate and iso-
Cancer Radiother, 22: 312–318. effect relationships for normal tissue responses. Int J Radiat
https://doi.org/10.1016/j.canrad.2017.11.011 Oncol Biol Phys, 8: 1981–1997.
36. Thames HD, 1985, An “incomplete-repair” model for https://doi.org/10.1016/0360-3016(82)90459-x
survival after fractionated and continuous irradiations. Int 47. Jani AB, Hand CM, Lujan AE, et al., 2004, Biological
J Radiat Biol Relat Stud Phys Chem Med, 47: 319–339. effective dose for comparison and combination of external
https://doi.org/10.1080/09553008514550461 beam and low-dose rate interstitial brachytherapy prostate
cancer treatment plans. Med Dosim, 29: 42–48.
37. Dikomey E, Brammer I, 2000, Relationship between cellular
radiosensitivity and non-repaired double-strand breaks https://doi.org/10.1016/j.meddos.2003.09.005
studied for different growth states, dose rates and plating 48. Antipas V, Dale RG, Coles IP, 2001, A theoretical
conditions in a normal human fibroblast line. Int J Radiat investigation into the role of tumour radiosensitivity,
Biol, 76: 773–781. clonogen repopulation, tumour shrinkage and radionuclide
https://doi.org/10.1080/09553000050028922 RBE in permanent brachytherapy implants of 125I and
103Pd. Phys Med Biol, 46: 2557–25569.
38. Deore SM, Sarin R, Dinshaw KA, et al., 1993, Influence of
dose-rate and dose per fraction on clinical outcome of breast https://doi.org/10.1088/0031-9155/46/10/304
cancer treated by external beam irradiation plus iridium-192 49. Ling CC, Li WX, Anderson LL, 1995, The relative biological
implants: Analysis of 289 cases. Int J Radiat Oncol Biol Phys, effectiveness of I-125 and Pd-103. Int J Radiat Oncol Biol
26: 601–606. Phys, 32: 373–378.
https://doi.org/10.1016/0360-3016(93)90275-z https://doi.org/10.1016/0360-3016(95)00530-C

Volume 1 Issue 2 (2023) 11 https://doi.org/10.36922/arnm.0914